Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open | $12.390 |
Close | $12.410 |
Volume / Avg. | 1.531M / 1.974M |
Day Range | 12.335 - 12.515 |
52 Wk Range | 9.480 - 15.150 |
Market Cap | $1.621B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 16.17% |
Days to Cover | 7.68 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: Immunome (NASDAQ:IMNM), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA) and Fusion Pharmaceuticals (NASDAQ:FUSN).
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by Goldman Sachs on Thursday, February 1, 2024. The analyst firm set a price target for 20.00 expecting DVAX to rise to within 12 months (a possible 61.16% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $12.41 last updated March 28, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Dynavax Technologies.
Dynavax Technologies’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.